(AP) -- The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effort to keep Avastin approved for breast cancer, despite evidence ...

Medicine & Health - Medications

Jun 27, 2011 5 / 5 (1) 0

Scientists believe they may have found a new target for treating triple negative breast cancer – one of the more difficult breast cancers to treat successfully and for which there is no targeted therapy at present.

Medicine & Health - Cancer

Nov 17, 2010 not rated yet 0